Pfizer asks FDA to authorize COVID-19 vaccine for young kids By Yasemin Saplakoglu published 7 October 21 Pfizer and BioNTech officially submitted a request to the FDA to approve their COVID-19 vaccine for children aged 5 to 11.
New antiviral pill halves risk of COVID-19 hospitalization, Merck says By Nicoletta Lanese published 1 October 21 Merck announced promising trial results this week, but the full data has yet to be released.
Viruses found in Laos bats are closest known relatives to SARS-CoV-2 By Rachael Rettner published 25 September 21 Strengthening case for natural origin.
COVID-19 has now killed as many people in the U.S. as the 1918 Spanish flu By Yasemin Saplakoglu published 21 September 21 The 1918-1919 flu pandemic led to approximately 675,000 deaths in the U.S.
Pfizer says its COVID-19 vaccine is safe and effective for younger kids By Yasemin Saplakoglu published 20 September 21 A lower dose of the vaccine showed to be safe, well-tolerated and effective in spurring antibodies in kids between 5 to 11 years of age, the company announced.
Pfizer & BioNTech will soon seek approval for COVID-19 vaccine in young children By Yasemin Saplakoglu published 10 September 21 The youngest age that a person can get a COVID-19 vaccine is 12. That may change soon.
2 scientists win $3 million 'Breakthrough Prize' for mRNA tech behind COVID-19 vaccines By Nicoletta Lanese published 9 September 21
New 'mu' coronavirus variant could escape vaccine-induced immunity, WHO says By Rachael Rettner published 2 September 21 The variant was first detected in Colombia in January 2021.
Huge, gold-standard study shows unequivocally that surgical masks work to reduce coronavirus spread By Yasemin Saplakoglu published 1 September 21 Results from a massive study in Bangladesh unequivocally show that surgical masks reduce the spread of SARS-CoV-2, scientists say.
Ivermectin won't treat COVID-19, but it might kill you, CDC warns By Rachael Rettner published 26 August 21 Ivermectin does not treat or prevent COVID-19, and it can cause deadly side effects.
Johnson & Johnson booster shot increases antibodies to coronavirus nine-fold, company says By Yasemin Saplakoglu published 25 August 21 People who received a booster Johnson & Johnson COVID-19 vaccine six to eight months after their initial dose had a nine-fold increase in antibodies, according to clinical trial results.
These delta variant mutations may explain its scary power By Stephanie Pappas published 25 August 21 These mutations may make delta the most transmissible coronavirus variant yet. Here's how the variant became so formidable.
'Shredder' enzyme might tear cells apart in severe COVID-19 By Nicoletta Lanese published 24 August 21 The enzyme could be a helpful target for future treatments, the study authors suggest.
FDA grants full approval for Pfizer-BioNTech coronavirus vaccine By Yasemin Saplakoglu published 23 August 21 The Food and Drug Administration granted full approval to Pfizer-BioNTech's COVID-19 vaccine on Monday (Aug.23). It's the first COVID-19 vaccine in the U.S. to be fully approved.
US to recommend COVID-19 vaccine booster shots 8 months post-vaccination By Yasemin Saplakoglu published 17 August 21 U.S. health officials are expected to recommend that people receive an additional COVID-19 vaccine dose eight months after their second dose.
Does the explosion of the delta variant mean we need a new COVID-19 vaccine? By Stephanie Pappas published 16 August 21 COVID-19 vaccines largely prevent severe illness, but the delta variant raises the question of whether and when booster shots will be needed.
COVID-19 could mix up body's 'fight-or-flight' system By Yasemin Saplakoglu published 16 August 21 There's still much that’s unknown about the subtle impacts a typical COVID-19 infection may have on the body and the nervous system.
Here's what you need to know about COVID-19 breakthrough infections By Yasemin Saplakoglu published 16 August 21 The COVID-19 vaccines that are used in the U.S. are highly effective. But sometimes, the coronavirus can still infect people who are vaccinated, causing so-called breakthrough infections.
How deadly is the coronavirus delta variant? By Rachael Rettner published 12 August 21 Early data suggests the delta variant may cause more severe disease.
FDA to authorize 3rd COVID-19 vaccine dose for immunocompromised people By Yasemin Saplakoglu published 11 August 21 The FDA is planning to update the emergency use authorizations for Pfizer and Moderna's COVID-19 vaccines to include a third dose for immunocompromised people.
